EUVIMEDEUVIMED entdecken
Open Access

Reducing hydrophobic drug adsorption in an in-vitro extracorporeal membrane oxygenation model

Nitish Khurana, Kamiya Watkins, Debika Ghatak, Jane Staples, Oliver Hubbard, Venkata Yellepeddi, Kevin Watt, Hamidreza Ghandehari

European Journal of Pharmaceutics and Biopharmaceutics · 2024

DOI: 10.1016/j.ejpb.2024.114261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2024. Verfasst von Nitish Khurana und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT, USA; Utah Center for Nanomedicine, University of Utah, Salt Lake City,…. Hauptthemen laut MEDLINE: Propofol, Extracorporeal Membrane Oxygenation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NCATS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracorporeal membrane oxygenation (ECMO) is a life-saving cardiopulmonary bypass technology for critically ill patients with heart and lung failure. Patients treated with ECMO receive a range of drugs that are used to treat underlying diseases and critical illnesses. However, the dosing guidelines for these drugs used in ECMO patients are unclear. Mortality rate for patients on ECMO exceeds 40% partly due to inaccurate dosing information, caused in part by the adsorption of drugs in the ECMO circuit and its components. These drugs range in hydrophobicity, electrostatic interactions, and pharmacokinetics. Propofol is commonly administered to ECMO patients and is known to have high adsorption rates to the circuit components due to its hydrophobicity. To reduce adsorption onto the circuit components, we used micellar block copolymers (Poloxamer 188TM and Poloxamer 407TM) and liposomes tethered with poly(ethylene glycol) to encapsulate propofol, provide a hydrophilic shell and prevent its adsorption. Size, polydispersity index (PDI), and zeta potential of the delivery systems were characterized by dynamic light scattering, and encapsulation efficiency was characterized using High Performance Liquid Chromatography (HPLC). All delivery systems used demonstrated colloidal stability at physiological conditions for seven days, cytocompatibility with a human leukemia monocytic cell line, i.e., THP-1 cells, and did not activate the complement pathway in human plasma. We demonstrated a significant reduction in adsorption of propofol in an in-vitro ECMO model upon encapsulation in micelles and liposomes. These results show promise in reducing the adsorption of hydrophobic drugs to the ECMO circuits by encapsulation in nanoscale structures tethered with hydrophilic polymers on the surface.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropofolExtracorporeal Membrane OxygenationHumansAdsorptionLiposomesHeartCritical Illness

Stichwörter der Autor:innen

AdsorptionECMOHydrophobic interactionsLiposomesMicellesPropofol

Substanzen

PropofolLiposomes

Autor:innen und Institutionen

  • Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT, USA; Utah Center for Nanomedicine, University of Utah, Salt Lake City, UT, USA; Division of Clinical Pharmacology, Department of Pediatrics,…
  • Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT, USA; Utah Center for Nanomedicine, University of Utah, Salt Lake City, UT, USA.
  • Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT, USA; Utah Center for Nanomedicine, University of Utah, Salt Lake City, UT, USA; Department of Biomedical Engineering, University of Utah, Sa…
  • Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT, USA; Division of Clinical Pharmacology, Department of Pediatrics, School of Medicine, University of Utah, Salt Lake City, UT, USA.

Förderung

  • NICHD NIH HHS
  • NCATS NIH HHS
  • National Institutes of Health
  • Frontiers Clinical and Translational Science Institute, University of Kansas
  • University of Utah
  • University of Utah School of Medicine Center for Clinical and Translational Science

Zitieren

APA

Khurana, N., Watkins, K., Ghatak, D., Staples, J., Hubbard, O., Yellepeddi, V., Watt, K., & Ghandehari, H. (2024). Reducing hydrophobic drug adsorption in an in-vitro extracorporeal membrane oxygenation model. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2024.114261

Vancouver

Khurana N, Watkins K, Ghatak D, Staples J, Hubbard O, Yellepeddi V, et al. Reducing hydrophobic drug adsorption in an in-vitro extracorporeal membrane oxygenation model. European Journal of Pharmaceutics and Biopharmaceutics. 2024. doi:10.1016/j.ejpb.2024.114261

BibTeX
@article{Khurana2024,
  author = {Khurana, Nitish and Watkins, Kamiya and Ghatak, Debika and Staples, Jane and Hubbard, Oliver and Yellepeddi, Venkata and Watt, Kevin and Ghandehari, Hamidreza},
  title = {Reducing hydrophobic drug adsorption in an in-vitro extracorporeal membrane oxygenation model},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2024},
  doi = {10.1016/j.ejpb.2024.114261}
}
Kostenlos starten →